From Device Defect to Herbicide Harm: Bard PowerPort + Roundup Strategy

Bard PowerPort: The Anatomy of a Defective Device

A medical device used on cancer patients should help them, not harm them. But the Bard PowerPort did the opposite in thousands of cases.

At MTMP, Jon and Marc sat down with Rebecca Phillips, Director of Mass Torts at The Lanier Law Firm and Co Lead Counsel in the Bard PowerPort MDL, to explain what's actually happening inside this litigation.

Inside this episode:

📊 The economics and market structure that make the tort viable

⚖️ The operational mindset behind MDL leadership and strategy

If you want to understand how real mass tort leaders think, this is the conversation worth paying attention to.

Roundup's Endgame

Roundup has been litigated for years, but this phase is not about proving harm. It is about leverage, timing, and how design defect claims stay alive no matter what happens on preemption.

This week’s Tort Talk features Seth Crompton, one of the most experienced Roundup litigators in the country, sitting down with Jon, Marc, and Joe at MTMP.

What you'll learn:

🎯 Why design defect claims remain strategically viable

📈 How inventory structure drives negotiation windows

⚖️ Where leverage is actually created in Roundup

🧭 What the next tactical moves look like for serious players

If you watch Roundup for the power dynamics, not the headlines, this is the episode that shows how the real leverage gets built.

Subscribe to The Jon & Marc Podcast on YouTube, Apple Podcasts, or Spotify for law firm growth strategies and legal marketing news from Jon, Marc, and the industry's top tier legal & marketing professionals.